Nexmed Logo
 
 
 
Key Personnel
Vivian Liu
President & C.E.O.
Ms. Liu was appointed to serve as President and Chief Executive Officer of the Company in June 2007, at which time she was elected to the Board of Directors for a three-year term. Ms. Liu served as Executive Vice President and Chief Operating Officer from June 2006 to June 2007, and as Secretary since 1995. Ms. Liu served as our Vice President of Corporate Affairs from September 1995 until December 2005, Acting Chief Executive Officer from December 2005 until January 2006, Chief Financial Officer from January 2004 until December 2005, Acting Chief Financial Officer from 1999 to January 2004 and Treasurer from September 1995 through December 2005. In 1994, while the Company was in a transition period, she served as Chief Executive Officer. From 1985 to 1994, Ms. Liu was a business and investment advisor to the government of Québec and numerous Canadian companies with respect to product distribution, technology transfer and investment issues. Ms. Liu received her MPA in International Finance from the University of Southern California and her BA from the University of California, Berkeley.
Hem Pandya
Vice President & C.O.O.
Mr. Pandya was appointed to the newly created position of Vice President and Chief Operating Officer in October 2007. Most recently, Mr. Pandya served as Chief Commercial Officer for Putney, Inc., a start-up veterinary pharmaceutical company. From August 2005 to December 2006, and prior to its merger with Watson Pharmaceuticals, Inc., Mr. Pandya was Senior Vice President of Business Development and Strategic Alliances for Andrx Pharmaceuticals, Inc., where he managed the licensing and co-development opportunities with strategic global partners. From August 2002 to August 2005, Mr. Pandya served as Vice President of Corporate Development and Commercial Operations for Able Laboratories, Inc. Prior to August 2002, Mr. Pandya served in various senior management positions with Ivax Pharmaceuticals, Inc. and Faulding/Purepac Pharmaceutical Company (subsequently Alpharma, Inc.). Mr. Pandya received his BA from Rutgers University.
Mark Westgate
Vice President & C.F.O.
Mr. Westgate was named Vice President and C.F.O. in December 2005. Mr. Westgate served as Controller from 2002-2005. Prior to joining NexMed, Mr. Westgate was Controller and Director of Finance for Lavipharm Laboratories Inc. from 1998-2002. Mr. Westgate was also a supervisor at Richard A. Eisner & Company, LLP where he performed audits and provided tax advice for many clients in various industries including the biotech industry. Mr. Westgate is a Certified Public Accountant and a member of the New York State Society of Certified Public Accountants. Mr. Westgate holds a B.B.A. in public accounting from Pace University.
   

Company Profile

Key Personnel

Partnerships

Careers
 
   
 
NexMed is an emerging drug developer that is leveraging its proprietary drug delivery technology to develop a significant pipeline of innovative pharmaceutical products to address large unmet medical needs. The Company is also working with various pharmaceutical companies to explore the incorporation of NexACT® into their existing drugs as a means of developing new patient-friendly transdermal products and extending patent lifespans and brand equity.